Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MNK - Mallinckrodt Will Likely Survive The Opioid Claims And Litigations

MNK - Mallinckrodt Will Likely Survive The Opioid Claims And Litigations

Mallinckrodt plc

Summary

  • Mallinckrodt develops and markets specialty pharmaceutical products for autoimmune and rare diseases.
  • In my view, investors really forgot about the potential future free cash flow that Mallinckrodt could generate.
  • Even considering the lawsuits, I believe that the stock price could be a bit undervalued.
  • If the company’s sales force successfully convinces new physicians, future financial figures will likely be better than expected.

For further details see:

Mallinckrodt Will Likely Survive The Opioid Claims And Litigations
Stock Information
Company Name: Mallinckrodt plc
Stock Symbol: MNK
Market: NYSE
Menu
MNK MNK Quote MNK Short MNK News MNK Articles MNK Message Board
Get MNK Alerts

News, Short Squeeze, Breakout and More Instantly...